Plasma cfDNA whole-exome sequencing to characterize tumor mutation landscape and track cancer evolution 

In the following Condalab Talks, Dr. Rodrigo Toledo will explain how they apply the ThruPLEX Plasma- seq technology to sequence cfDNA of sequential plasma samples of patients collected before, during, and at progression to different cancer therapies.

Topics discussed:

- Usage of ThruPLEX Plasma-seq to:

1) Identify new mechanisms of resistance to cancer therapies.

2) Track cancer clonal evolution.

3) Evaluate the role of cfDNA on the survival of patients treated with cancer immunotherapy.